v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Sales, net of returns and allowances $ 4,329 $ 1,145
Cost of sales 11,811 2,224
Gross loss (7,482) (1,079)
Operating expenses:    
Selling, general and administrative 9,545 4,340
Research and development 4,069 3,660
Total operating expenses 13,614 8,000
Loss from operations (21,096) (9,079)
Interest expense, net (354) (3,576)
Change in fair value of convertible note (145) 0
Change in fair value of stock rights 1,703 0
Other expense (24) (1)
Loss before benefit for income taxes (19,916) (12,656)
Benefit for income taxes 34 0
Net loss $ (19,882) $ (12,656)
Net loss per share of common stock - basic (in dollars per share) $ (1.99) $ (1.36)
Net loss per share of common stock - diluted (in dollars per share) $ (1.99) $ (1.36)
Weighted-average shares used in computing net loss per share of common stock - basic (in shares) 10,014 9,329
Weighted-average shares used in computing net loss per share of common stock - diluted (in shares) 10,014 9,329

Source